Operating Cash Flow (Statement)

$1.90B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$1.90Bperiod endingJun 30, 2026

TEVA Cash from Operations ($9.10M → $1.90B)

Annual operating cash flow (statement)

High-resolution chart · PNG

TEVA operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	1,649,000,000
Dec 31, 2024	1,247,000,000
Dec 31, 2023	1,368,000,000
Dec 31, 2022	1,590,000,000
Dec 31, 2021	798,000,000
Dec 31, 2020	1,216,000,000
Dec 31, 2019	538,000,000
Dec 31, 2018	2,446,000,000
Dec 31, 2017	3,507,000,000
Dec 31, 2016	5,225,000,000
Dec 31, 2015	5,542,000,000
Dec 31, 2014	5,127,000,000
Dec 31, 2013	3,237,000,000
Dec 31, 2012	4,572,000,000
Dec 31, 2011	4,134,000,000
Dec 31, 2010	4,136,000,000
Dec 31, 2009	3,373,000,000
Dec 31, 2008	3,231,000,000
Dec 31, 2007	1,813,000,000
Dec 31, 2006	2,058,000,000
Dec 31, 2005	1,370,000,000
Dec 31, 2004	1,248,800,000
Dec 31, 2003	626,600,000
Dec 31, 2002	353,700,000
Dec 31, 2001	273,148,000
Dec 31, 2000	165,626,000
Dec 31, 1999	153,607,000
Dec 31, 1998	70,200,000
Dec 31, 1997	193,600,000
Dec 31, 1996	-6,800,000
Dec 31, 1995	105,400,000
Dec 31, 1994	38,200,000
Dec 31, 1993	37,700,000
Dec 31, 1992	28,200,000
Dec 31, 1991	9,100,000